RU2468019C2 - Сероводородные производные нестероидных противовоспалительных лекарственных средств - Google Patents

Сероводородные производные нестероидных противовоспалительных лекарственных средств Download PDF

Info

Publication number
RU2468019C2
RU2468019C2 RU2009105491/04A RU2009105491A RU2468019C2 RU 2468019 C2 RU2468019 C2 RU 2468019C2 RU 2009105491/04 A RU2009105491/04 A RU 2009105491/04A RU 2009105491 A RU2009105491 A RU 2009105491A RU 2468019 C2 RU2468019 C2 RU 2468019C2
Authority
RU
Russia
Prior art keywords
compound
compound according
diclofenac
treatment
patient
Prior art date
Application number
RU2009105491/04A
Other languages
English (en)
Russian (ru)
Other versions
RU2009105491A (ru
Inventor
Джон Л. УОЛЛЭЙС
Джузеппе ЧИРИНО
Винченцо САНТАГАДА
Джузеппе КАЛЕНДО
Original Assignee
Антиб Терапьютикс Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Антиб Терапьютикс Инк. filed Critical Антиб Терапьютикс Инк.
Publication of RU2009105491A publication Critical patent/RU2009105491A/ru
Application granted granted Critical
Publication of RU2468019C2 publication Critical patent/RU2468019C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C219/14—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the hydroxy groups esterified by a carboxylic acid having the esterifying carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/38—Amides of thiocarboxylic acids
    • C07C327/48—Amides of thiocarboxylic acids having carbon atoms of thiocarboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02—Five-membered rings
    • C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
RU2009105491/04A 2006-07-18 2007-07-18 Сероводородные производные нестероидных противовоспалительных лекарственных средств RU2468019C2 (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US80763906P 2006-07-18 2006-07-18
US60/807,639 2006-07-18
US88718807P 2007-01-30 2007-01-30
US60/887,188 2007-01-30
PCT/CA2007/001289 WO2008009127A1 (en) 2006-07-18 2007-07-18 Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs

Publications (2)

Publication Number Publication Date
RU2009105491A RU2009105491A (ru) 2010-08-27
RU2468019C2 true RU2468019C2 (ru) 2012-11-27

Family

ID=38956479

Family Applications (2)

Application Number Title Priority Date Filing Date
RU2009105491/04A RU2468019C2 (ru) 2006-07-18 2007-07-18 Сероводородные производные нестероидных противовоспалительных лекарственных средств
RU2009105498/04A RU2465271C2 (ru) 2006-07-18 2007-07-18 4-гидрокситиобензамидные производные лекарственных веществ

Family Applications After (1)

Application Number Title Priority Date Filing Date
RU2009105498/04A RU2465271C2 (ru) 2006-07-18 2007-07-18 4-гидрокситиобензамидные производные лекарственных веществ

Country Status (17)

Country Link
US (1) US8314140B2 (https=)
EP (2) EP2041108B1 (https=)
JP (2) JP5529534B2 (https=)
KR (2) KR101450653B1 (https=)
AU (2) AU2007276679B2 (https=)
BR (2) BRPI0714330A2 (https=)
CA (2) CA2658429A1 (https=)
DK (1) DK2057139T3 (https=)
ES (1) ES2437223T3 (https=)
IL (2) IL196229A (https=)
MX (2) MX2009000749A (https=)
NO (2) NO20090764L (https=)
NZ (1) NZ573996A (https=)
PL (1) PL2057139T3 (https=)
PT (1) PT2057139E (https=)
RU (2) RU2468019C2 (https=)
WO (2) WO2008009118A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7741359B2 (en) * 2005-05-27 2010-06-22 Antibe Therapeutics Inc. Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs
DK2057139T3 (da) * 2006-07-18 2013-11-18 Antibe Holdings Inc Hydrogensulfidderivater af non-steroide anti-inflammatoriske lægemidler
ITMI20080382A1 (it) * 2008-03-07 2009-09-08 Ctg Pharma S R L Composizioni farmaceutiche oculari
ITMI20081167A1 (it) * 2008-06-26 2009-12-27 Ctg Pharma S R L Composizioni farmaceutiche per il trattamento di malattie neurodegenerative
US8541396B2 (en) 2009-04-24 2013-09-24 National University Of Singapore Morpholin-4-ium 4 methoxyphenyl (morpholino) phosphinodithioate (GYY4137) as a novel vasodilator agent
WO2011053597A1 (en) * 2009-10-26 2011-05-05 The University Of Memphis Research Foundation Pipemidic acid derivative autotaxin inhibitors
US9242009B2 (en) 2012-07-17 2016-01-26 The General Hospital Corporation Compositions and methods to treat neurodegenerative diseases
AU2017263574B2 (en) 2016-05-12 2022-11-17 The Regents Of The University Of Michigan ASH1L inhibitors and methods of treatment therewith
WO2019094772A1 (en) 2017-11-10 2019-05-16 The Regents Of The University Of Michigan Ash1l degraders and methods of treatment therewith
JP2021066660A (ja) * 2018-02-09 2021-04-30 アピオン・ジャパン有限会社 Ｔｉｒａｐ阻害剤
WO2022115952A1 (en) * 2020-12-03 2022-06-09 Antibe Therapeutics Inc. [1-(4-chloro-benzoyl)-5-methoxy-2-methyl-1h-indol-3-yl]-acetic acid 4-thiocarbamoyl-phenyl ester for the treatment of a viral infection
WO2023159296A1 (en) * 2022-02-28 2023-08-31 Antibe Therapeutics Inc. 4-thiocarbamoylphenyl 2-(4-oxophenyl)-phenyl propanoate for the treatment of pain associated with urologic chronic pelvic pain syndrome
GR1010438B (el) * 2022-03-21 2023-04-06 UNI-PHARMA ΚΛΕΩΝ ΤΣΕΤΗΣ ΦΑΡΜΑΚΕΥΤΙΚΑ ΕΡΓΑΣΤΗΡΙΑ ΑΒΕΕ με δ.τ. "UNI-PHARMA ABEE", Φαρμακευτικες ενωσεις που βασιζονται στο συνδυασμο ενος ανταγωνιστη της ισταμινης και ενος δοτη υδροθειου για χρηση στην αντιμετωπιση του κνησμου
WO2025076616A1 (en) * 2023-10-11 2025-04-17 Antibe Therapeutics Inc. Polymorphic forms of otenaproxesul and compositions and uses thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2264383C2 (ru) * 1999-08-12 2005-11-20 Никокс С.А. Лекарственные вещества и фармацевтические композиции на их основе для использования в случаях окислительного стресса
WO2006066894A1 (en) * 2004-12-24 2006-06-29 Ctg Pharma S.R.L. Compounds for treating metabolic syndrome

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE612252A (https=) * 1961-01-05
US4170654A (en) * 1976-02-13 1979-10-09 Merck & Co., Inc. Antihypertensive compositions containing N-heterocyclicalanines and α-
US4112095A (en) * 1976-10-07 1978-09-05 American Cyanamid Company 6-Phenyl-1,2,4-triazolo[4,3-b]pyridazine hypotensive agents
US5214191A (en) * 1990-05-22 1993-05-25 Cortech, Inc. Oxidant sensitive and insensitive aromatic esters as inhibitors of human neutrophil elastase
US5663416A (en) * 1990-05-22 1997-09-02 Cortech Inc. Oxidant sensitive and insensitive aromatic esters as inhibitors of human neutrophil elastase
EP0937711A1 (de) 1998-02-18 1999-08-25 Roche Diagnostics GmbH Neue Thiobenzamide, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
IT1311924B1 (it) * 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
US6429223B1 (en) * 2000-06-23 2002-08-06 Medinox, Inc. Modified forms of pharmacologically active agents and uses therefor
US7638513B2 (en) * 2004-06-02 2009-12-29 Schering Corporation Compounds for the treatment of inflammatory disorders
EP1630164A1 (en) * 2004-08-31 2006-03-01 Expotrend Company SA Pyrazolopyrimidinones as phosphodiesterase inhibitors
EP1645288A1 (en) * 2004-10-07 2006-04-12 CTG Pharma S.r.l. New nuclear transcription factors regulators
CN2757375Y (zh) * 2004-11-25 2006-02-08 富士康(昆山)电脑接插件有限公司 电子卡连接器
CA2601381A1 (en) 2005-03-24 2006-09-28 Nycomed Gmbh 6-thioamide substituted benzimidazoles
ITMI20050680A1 (it) * 2005-04-18 2006-10-19 Ctg Pharma S R L Nuovi composti anti-infiammatori
US7498355B2 (en) 2005-05-27 2009-03-03 Antibe Therapeutics Inc. Derivatives of 4- or 5-aminosalicylic acid
WO2006125293A1 (en) * 2005-05-27 2006-11-30 Antibe Therapeutics Inc. Derivatives of 4- or 5-aminosalicylic acid
US20060270635A1 (en) 2005-05-27 2006-11-30 Wallace John L Derivatives of 4- or 5-aminosalicylic acid
DK2057139T3 (da) * 2006-07-18 2013-11-18 Antibe Holdings Inc Hydrogensulfidderivater af non-steroide anti-inflammatoriske lægemidler

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2264383C2 (ru) * 1999-08-12 2005-11-20 Никокс С.А. Лекарственные вещества и фармацевтические композиции на их основе для использования в случаях окислительного стресса
WO2006066894A1 (en) * 2004-12-24 2006-06-29 Ctg Pharma S.R.L. Compounds for treating metabolic syndrome

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BHATIA M. et al. Treatment with H2S-releasing derivative of diclofenac reduces inflammation in carrageenan-induced hindpaw oedema//Inflammation Research, Suppl. 2, 7 th World Congress on Inflammation, 20-24 August 2005, Melbourne. FIORUCCI S. et al. The Emerging Roles of Hydrogen Sulfide in the Gastrointestinal Tract and Liver//Gastroenterology, July 2006, vol.131, no.1 p.259-271. KOUROUNAKIS N. et al. Reduction of gastrointestinal toxicity of NSAIDs via molecular modifications leading to antioxidant anti-inflammatory drugs//Toxicology (2000), vol.144, no.1-3, p.205-210. GALANAKIS D. Synthesis and pharmacological evaluation of amide conjugates of NSAIDs with L-cysteine ethyl ester, combining potent anti-inflammatory and antioxidant properties with significantly reduced gastrointestinal toxicity//Bioorganic & Medicinal Chemistry Letters, vol.14, 2004, p.p.3693-3643. *
BHATIA M. et al. Treatment with H2S-releasing derivative of diclofenac reduces inflammation in carrageenan-induced hindpaw oedema//Inflammation Research, Suppl. 2, 7World Congress on Inflammation, 20-24 August 2005, Melbourne. *
FIORUCCI S. et al. The Emerging Roles of Hydrogen Sulfide in the Gastrointestinal Tract and Liver//Gastroenterology, July 2006, vol.131, no.1 p.259-271. *
GALANAKIS D. Synthesis and pharmacological evaluation of amide conjugates of NSAIDs with L-cysteine ethyl ester, combining potent anti-inflammatory and antioxidant properties with significantly reduced gastrointestinal toxicity//Bioorganic & Medicinal Chemistry Letters, vol.14, 2004, p.p.3693-3643. *
KOUROUNAKIS N. et al. Reduction of gastrointestinal toxicity of NSAIDs via molecular modifications leading to antioxidant anti-inflammatory drugs//Toxicology (2000), vol.144, no.1-3, p.205-210. *

Also Published As

Publication number Publication date
EP2041108A1 (en) 2009-04-01
HK1131973A1 (en) 2010-02-12
JP2009543813A (ja) 2009-12-10
NO20090764L (no) 2009-04-16
BRPI0714466B8 (pt) 2021-05-25
PL2057139T3 (pl) 2014-06-30
AU2007276621A1 (en) 2008-01-24
AU2007276621B2 (en) 2013-08-01
WO2008009118A1 (en) 2008-01-24
RU2009105498A (ru) 2010-08-27
AU2007276679B2 (en) 2013-05-30
MX2009000750A (es) 2009-01-30
PT2057139E (pt) 2013-12-05
IL196229A (en) 2016-04-21
KR101495520B1 (ko) 2015-02-26
NZ573996A (en) 2012-03-30
CA2658429A1 (en) 2008-01-24
EP2057139B1 (en) 2013-09-04
BRPI0714466A2 (pt) 2013-05-14
DK2057139T3 (da) 2013-11-18
ES2437223T3 (es) 2014-01-09
MX2009000749A (es) 2009-01-30
BRPI0714330A2 (pt) 2013-05-07
CA2658433C (en) 2015-04-28
KR20090036115A (ko) 2009-04-13
EP2057139A1 (en) 2009-05-13
RU2009105491A (ru) 2010-08-27
IL196228A0 (en) 2009-09-22
JP2009543811A (ja) 2009-12-10
JP5529534B2 (ja) 2014-06-25
KR101450653B1 (ko) 2014-10-14
BRPI0714466B1 (pt) 2020-09-24
EP2057139A4 (en) 2010-09-15
NO342083B1 (no) 2018-03-19
RU2465271C2 (ru) 2012-10-27
KR20090040428A (ko) 2009-04-24
EP2041108A4 (en) 2010-12-29
AU2007276679A1 (en) 2008-01-24
HK1131125A1 (en) 2010-01-15
JP5408719B2 (ja) 2014-02-05
US8314140B2 (en) 2012-11-20
CA2658433A1 (en) 2008-01-24
WO2008009127A1 (en) 2008-01-24
NO20090763L (no) 2009-04-03
IL196229A0 (en) 2009-09-22
US20090306412A1 (en) 2009-12-10
EP2041108B1 (en) 2014-05-21

Similar Documents

Publication Publication Date Title
RU2468019C2 (ru) Сероводородные производные нестероидных противовоспалительных лекарственных средств
US7741359B2 (en) Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs
CN101238137B (zh) 4-或5-氨基水杨酸的衍生物
ES2296616T3 (es) Composiciones farmaceuticas.
US20110098257A1 (en) Derivatives of 4- or 5-aminosalicylic acid
CN101501018A (zh) 非甾体抗炎药的硫化氢衍生物
US6620813B1 (en) Hydroxamate derivatives of non-steroidal anti-inflammatory drugs
CA2608627A1 (en) Novel nsaids possessing a nitric oxide donor diazen-1-ium-1,2-diolate moiety
US20040077691A1 (en) Hydroxamate derivatives of non-steroidal anti-inflammatory drugs
HK1131973B (en) Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs
HK1121163B (en) Derivatives of 4-or 5-aminosalicylic acid
HK1131125B (en) 4-hydroxythiobenzamide derivatives of drugs

Legal Events

Date Code Title Description
PD4A Correction of name of patent owner